thisdrug what a medicine's name tells you

WHO naming stem · suffix · 13 listed names

-clidine/-clidinium

muscarinic receptor agonists/antagonists

WHO's definition, quoted as written in the 2024 stem book
Names only. This page is about -clidine/-clidinium as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as -clidine/-clidinium. It has 2 spellings or places: clidine at the end of the name (…clidine); clidinium at the end of the name (…clidinium).

Of the 13 names WHO lists under it, 10 carry clidine at the end of the name, 3 carry clidinium at the end of the name.

All 13 names WHO lists under -clidine/-clidinium

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

  1. aclidinium bromide
  2. benzoclidine
  3. droclidinium bromide
  4. emraclidine
  5. eticyclidine
  6. gacyclidine
  7. phencyclidine
  8. procyclidine
  9. rolicyclidine
  10. talsaclidine
  11. tenocyclidine
  12. umeclidinium bromide
  13. vedaclidine

Decode another name

Decoded

emraclidine

Listed INNCarries the WHO stem -clidine/-clidinium

  • -clidine/-clidiniumend of the nameWHO lists it hereWHO definition: muscarinic receptor agonists/antagonists

“emraclidine” is an INN that WHO lists under -clidine/-clidinium in the 2024 stem book.

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of -clidine/-clidinium (Part II B) and the 13 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.